News

Teamwork is key for cancer-fighting proteins

The mechanisms that orchestrate the functions of our bodies and keep us healthy are quite complex, involving critical molecular components that are still poorly understood. The prestigious journal Nature Communications has published recent research on this topic by a team led by Dr. El Bachir Affar, a professor in the Department of Medicine, Faculty of […]

A precise target to tackle obesity: summary of the article co-signed by Michel Bouvier’s team in PNAS

By Martin Primeau Researchers from the University of Copenhagen and the team of Michel Bouvier at the IRIC just published a study suggesting a new avenue for developing drugs against obesity. The results of this research were published this week in the journal PNAS. According to Health Canada, approximately 64% of Canadian adults are currently […]

A drug reveals its secrets

By Martin Primeau The team of professor Sylvie Mader at IRIC just published a study, conducted by Dr. Tatiana Traboulsi and her colleagues, which explains the mechanism of action of certain anti-estrogen drugs such as fulvestrant, a drug clinically known as Faslodex. The results of this research were recently published in the journal Oncogene. About […]

KO Cancer 2018

The second round of KO Cancer that took place last Friday, raised an extraordinary amount of $125,000. Although the event took place on the ring, the true fight against cancer is an ongoing battle for all.  Everyone can help support the research efforts conducted at the IRIC and every contribution counts by helping end this scourge.    Thank […]

Dr. Guy Sauvageau elected to the Academy of Science of the Royal Society of Canada

  Montreal, September 11, 2018– Dr. Guy Sauvageau, Principal Investigator at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal and hematologist at the Maisonneuve-Rosemont Hospital (CIUSSS de l’Est-de-l’Île-de-Montréal), has been elected a member of the Academy of Science of the Royal Society of Canada (RSC).   A multidisciplinary commitment […]

The Montreal Alouettes: proud IRIC supporters and donors

The Montreal Alouettes support the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal through its Matching Gifts Program. The Alouettes’ organization agrees to match each individual donation made to the Institute, thus doubling the impact of the donations received. The IRIC also wishes to recognize the Montreal Alouettes’ energy and benevolence, […]

CIHR announcement

On August 13th 2018, an announcement was held at the Agora, in the presence of the Honourable Ginette Petitpas Taylor – Minister of Health, to highlight the work of the Canadian Institutes of Health Research (CIHR) recipients.    Kathy Borden and Marc Therrien each received a grant from the CIHR, as part of the 2018 Project Grant Spring competition […]

IRICoR receives 25 million dollars to support its research commercialization activities as part of the 2018 CECR competition

Montreal, July 30, 2018 — IRICoR (Institute for Research in Immunology and Cancer – Commercialization of Research), a drug discovery and commercialization cluster, is proud to announce that it has received substantial support from the federal government in the amount of 25 million dollars, as part of the 2018 edition of the Centres of Excellence […]

Two IRIC investigators receive a grant from the Canadian Institutes of Health Research

Kathy Borden and Marc Therrien each recently received a grant from the Canadian Institutes of Health Research (CIHR), respectively as part of the Project Grant: Spring 2018 competition and the Foundation Grant: 2017-2018 competition. Kathy Borden, Principal Investigator, Structure and Function of the Cell Nucleus research unit at the IRIC and Full Professor, Department of […]

« Previous Page | Next Page »

Follow IRIC

Logo UdeM